Back
Xylem, Inc. Vs. Apellis Pharmaceuticals, Inc. Industry Stock Comparison
Buy
62
XYL
Xylem, Inc.
Last Price:
$139.42
Seasonality Move:
1.18%
Sell
36
APLS
Apellis Pharmaceuticals, Inc.
Last Price:
$26.47
Seasonality Move:
2.66%
Buy
62
Xylem, Inc. (XYL)
is a Buy
Is Xylem, Inc. a Buy, Sell or Hold?
-
The current Xylem, Inc. [XYL] share price is $141.33. The Score for XYL is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
XYL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Apellis Pharmaceuticals, Inc. (APLS)
is a Sell
Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals, Inc. [APLS] share price is $23.94. The Score for APLS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XYL Stock Price Chart
What is Xylem, Inc.'s stock price today?
-
The Xylem, Inc. share price today is $141.33The current trend is relatively stagnant and XYL is experiencing buying pressure, which is a positive indicator for future bullish movement.
APLS Stock Price Chart
What is Apellis Pharmaceuticals, Inc.'s stock price today?
-
The Apellis Pharmaceuticals, Inc. share price today is $23.94Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
XYL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.71 | Sell |
| Relative Strength Index (14 RSI): | 56.87 | Buy |
| Chaikin Money Flow: | 854958 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (137.18 - 139.84) | Buy |
| Bollinger Bands (100): | (138.67 - 147.41) | Sell |
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.59 | Buy |
| Relative Strength Index (14 RSI): | 48.27 | Sell |
| Chaikin Money Flow: | -1351238 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.59 - 25.53) | Sell |
| Bollinger Bands (100): | (21.4 - 27.16) | Sell |
XYL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 138.39 | Buy |
| 20-day SMA: | 138.16 | Buy |
| 50-day SMA: | 142.44 | Sell |
| 200-day SMA: | 134.27 | Buy |
| 8-day EMA: | 138.69 | Buy |
| 20-day EMA: | 138.86 | Buy |
| 50-day EMA: | 140.67 | Buy |
| 200-day EMA: | 136.93 | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.91 | Sell |
| 20-day SMA: | 24.75 | Sell |
| 50-day SMA: | 23.01 | Buy |
| 200-day SMA: | 21.91 | Buy |
| 8-day EMA: | 24.76 | Sell |
| 20-day EMA: | 24.34 | Sell |
| 50-day EMA: | 23.66 | Buy |
| 200-day EMA: | 24.33 | Sell |
Xylem, Inc. Earnings Growth & XYL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.61 per share.
Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.44 per share, and an increase next year of $0.91 per share.
Xylem, Inc. Technical Analysis
| Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apellis Pharmaceuticals, Inc. Technical Analysis
| Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||